1. Home
  2. CCEL vs VHC Comparison

CCEL vs VHC Comparison

Compare CCEL & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • VHC
  • Stock Information
  • Founded
  • CCEL 1989
  • VHC 2005
  • Country
  • CCEL United States
  • VHC United States
  • Employees
  • CCEL N/A
  • VHC N/A
  • Industry
  • CCEL Managed Health Care
  • VHC Multi-Sector Companies
  • Sector
  • CCEL Health Care
  • VHC Miscellaneous
  • Exchange
  • CCEL Nasdaq
  • VHC Nasdaq
  • Market Cap
  • CCEL 39.9M
  • VHC 35.7M
  • IPO Year
  • CCEL 1997
  • VHC 1999
  • Fundamental
  • Price
  • CCEL $5.13
  • VHC $7.55
  • Analyst Decision
  • CCEL Strong Buy
  • VHC
  • Analyst Count
  • CCEL 1
  • VHC 0
  • Target Price
  • CCEL $8.50
  • VHC N/A
  • AVG Volume (30 Days)
  • CCEL 8.3K
  • VHC 19.5K
  • Earning Date
  • CCEL 07-14-2025
  • VHC 08-13-2025
  • Dividend Yield
  • CCEL 7.97%
  • VHC N/A
  • EPS Growth
  • CCEL N/A
  • VHC N/A
  • EPS
  • CCEL 0.01
  • VHC N/A
  • Revenue
  • CCEL $32,102,750.00
  • VHC $3,000.00
  • Revenue This Year
  • CCEL $2.49
  • VHC N/A
  • Revenue Next Year
  • CCEL $0.95
  • VHC N/A
  • P/E Ratio
  • CCEL $555.99
  • VHC N/A
  • Revenue Growth
  • CCEL 2.33
  • VHC N/A
  • 52 Week Low
  • CCEL $4.75
  • VHC $3.68
  • 52 Week High
  • CCEL $9.43
  • VHC $13.89
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 50.16
  • VHC 41.62
  • Support Level
  • CCEL $5.00
  • VHC $7.60
  • Resistance Level
  • CCEL $5.31
  • VHC $9.05
  • Average True Range (ATR)
  • CCEL 0.22
  • VHC 1.24
  • MACD
  • CCEL 0.02
  • VHC -0.16
  • Stochastic Oscillator
  • CCEL 43.09
  • VHC 12.94

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

Share on Social Networks: